C. Antier
AuthID: R-00J-W2S
1
TITLE: Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 10.1007/s00259-020-05015-2)
AUTHORS: Manson, G; Brice, P; Herbaux, C; Silva, MG; Bouabdallah, K; Deau, B; Bouteloup, J; Schiano, JM; Nicolas Virelizier, E; Maerevoet, M; Ghesquieres, H; Stamatoullas, A; Antier, C; Carlo Stella, C; de Charette, M; Poizeau, F; Dercle, L; Houot, R;
PUBLISHED: 2021, SOURCE: European Journal of Nuclear Medicine and Molecular Imaging
AUTHORS: Manson, G; Brice, P; Herbaux, C; Silva, MG; Bouabdallah, K; Deau, B; Bouteloup, J; Schiano, JM; Nicolas Virelizier, E; Maerevoet, M; Ghesquieres, H; Stamatoullas, A; Antier, C; Carlo Stella, C; de Charette, M; Poizeau, F; Dercle, L; Houot, R;
PUBLISHED: 2021, SOURCE: European Journal of Nuclear Medicine and Molecular Imaging
INDEXED IN: 
Scopus
Scopus